VINOH: Ventricular Size Involvement in Neuropsychological Outcomes in Pediatric Hydrocephalus

Sponsor
University of Utah (Other)
Overall Status
Completed
CT.gov ID
NCT01797627
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (NIH), Hydrocephalus Association (Other)
78
8
60
9.8
0.2

Study Details

Study Description

Brief Summary

This multicenter, prospective study of children with hydrocephalus will examine whether or not ventricle size is associated with poor cognitive outcomes. It is expected that results will indicate larger ventricular size at 6 months after surgery for the initial treatment of hydrocephalus will relate to poorer cognitive outcomes. This study is being conducted by the Hydrocephalus Clinical Research Network (HCRN), a network established to conduct multi-institutional clinical trials on pediatric hydrocephalus.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The current literature is inconclusive regarding the direct association between large ventricle size and poorer cognitive outcomes. This uncertainty stems from relatively few studies, problems with study design (possible confounding factors), varying study populations of hydrocephalus, and conflicting evidence. If the association is proven then aggressive strategies must be developed to maximally decrease ventricular size in these children to preserve long-term cognitive functioning. However, if the association is disproven then previous reservations for procedures such as Endoscopic Third Ventriculostomy (ETV) or higher-resistance shunting to prevent overdrainage complications will be further minimized. Either finding has a major potential to further improve the quality of life in our pediatric hydrocephalus patients. This study is unique as it will include pediatric patients presenting with hydrocephalus from a wide range of etiologies. This study is also unique in that we propose to conduct a brief pre-operative neuropsychological examination to act as internal controls along with the outcomes obtained at a more extensive neuropsychological examination at six months after initial hydrocephalus treatment surgery.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    78 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Ventricular Size Involvement in Neuropsychological Outcomes in Pediatric Hydrocephalus (VINOH)
    Actual Study Start Date :
    Aug 1, 2011
    Actual Primary Completion Date :
    Jul 1, 2016
    Actual Study Completion Date :
    Aug 1, 2016

    Outcome Measures

    Primary Outcome Measures

    1. Association between ventricle size and neuropsychological outcome [6 months after initial surgical treatment for hydrocephalus]

      Ventricle size, measured as fronto-occipital horn ratio (FOR), as well as neuropsychological outcomes at 6 months post-surgical intervention for initial treatment of hydrocephalus will be compared.

    Secondary Outcome Measures

    1. Quality of life [6 months after initial surgical treatment for hydrocephalus]

      The Hydrocephalus Outcome Questionnaire (HOQ) will be administered at approximately 6 months. The HOQ is a validated measure of quality of life specific to the pediatric hydrocephalus population.

    2. Academic Performance [6 months after initial surgical treatment for hydrocephalus]

      Parents will be asked to provide a picture of their child's current academic performance. If available, the child's most recent grade point average (GPA) will be obtained.

    3. Presence of additional required hydrocephalus related surgeries [6 months after initial surgical treatment for hydrocephalus]

      Shunt and ETV revisions or infections will be examined for any correlations with cognitive neuropsychological testing at 6 months from the initial surgical intervention.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria: Patients will be eligible for enrollment if they:
    • are 5 years of age or older; and

    • have been newly diagnosed with hydrocephalus to be managed surgically with either a cerebrospinal fluid (CSF) shunt or an ETV; and

    • have one of the following etiologies for hydrocephalus: aqueductal stenosis, supratentorial and posterior fossa tumors both benign and malignant, post-traumatic, myelomeningocele, tectal gliomas, post-infectious, and following spontaneous intraventricular hemorrhage (IVH). Malignant tumors have been included as the neuropsychological deficits secondary to adjuvant chemotherapy and radiation have not been demonstrated within the proposed study's 6 month window.

    Exclusion Criteria: Patients will be ineligible for enrollment if ANY of the following is true or anticipated:

    • present with a Glasgow Coma Scale (GCS) score of less than 14/15, cerebellar mutism, or cognitive deficits so severe as to make neuropsychological testing impossible; OR

    • have etiologies of diffuse intrinsic pontine glioma, atypical teratoid rhabdoid tumor, or any tumor with cerebral or spinal metastases (these patients' clinical course and survival are highly unpredictable); OR

    • are not expected to survive for 6 months; OR

    • are unable or unwilling to participate in the study and with the neuropsychological exam; OR

    • due to limitations of neuropsychological testing, blind and deaf children will be excluded. Children for whom English is not their primary language will be included if they have attended 1 or more years of English language based schooling.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children's Hospital of Alabama, University of Alabama Birmingham Alabama United States 35233
    2 St. Louis Children's Hospital Saint Louis Missouri United States 63110
    3 Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania United States 15224
    4 Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville Tennessee United States 37232
    5 Texas Children's Hospital Houston Texas United States 77030
    6 Primary Children's Hospital Salt Lake City Utah United States 84118
    7 Seattle Children's Hospital Seattle Washington United States 98105
    8 Sick Children's Hospital Toronto Ontario Canada

    Sponsors and Collaborators

    • University of Utah
    • National Institute of Neurological Disorders and Stroke (NINDS)
    • Hydrocephalus Association

    Investigators

    • Study Chair: Jay Riva-Cambrin, MD, MSc, Alberta Children's Hospital
    • Principal Investigator: Richard Holubkov, Ph.D., University of Utah

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    richard holubkov, Ph.D., University of Utah
    ClinicalTrials.gov Identifier:
    NCT01797627
    Other Study ID Numbers:
    • 49237
    • 1RC1NS068943-01
    • HCRN 006
    First Posted:
    Feb 22, 2013
    Last Update Posted:
    Jan 29, 2020
    Last Verified:
    Jan 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by richard holubkov, Ph.D., University of Utah
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 29, 2020